The One Thing in Your Deal That Is Not Yours to Sell

A buyer's attorney opened a call with me recently the way they almost always do: “We'll structure this as an asset purchase.” In most industries, a reasonable opening position. In New Jersey cannabis it does not survive contact with the rulebook — and the sooner both sides know it, the more of the negotiation is left for what is actually negotiable.

Here is the decision tree, in the order the questions come up. Six decisions. Most New Jersey deals resolve all six the same way, but the reasons are where the money is.

1. Is a license part of what you are selling?

If it is not — a building, equipment, a brand — stop here. Ordinary asset-sale rules apply and none of what follows changes your life.

If it is, the structure is largely decided for you. New Jersey sits with California in the state-by-state pattern: the license cannot be assigned to another party or another premises. What the regulator vets instead is a change of ownership in the entity that already holds it, while the license stays put. So New Jersey deals move membership interests or stock, not a schedule of assets. Nobody is buying the license. They are buying the company it is attached to.

2. How long have you been operating?

N.J.A.C. 17:30-9.3 does not permit a license holder to change more than 50 percent of its ownership interest from the submission of a conditional-conversion or annual license application until at least two years after the business commences operations. There is a carve-out for transfers from a deceased owner to an heir, or to a surviving spouse or partner on a jointly issued license. The Commission also “retains discretion to determine when a transfer of ownership interests has occurred” — worth reading twice before anyone gets clever with a two-step structure.

The part sellers miss: a business that ceases operations inside those two years cannot transfer its license at all. It is abandoned and returned to the Commission. If your plan for a bad year is to close the doors and sell the paper afterwards, there is no paper to sell — which cuts the opposite way from the math in yesterday's buy-versus-build piece.

3. What has to be approved, and by whom?

N.J.A.C. 17:30-9.2 treats an ownership change as a material change, alongside a change of management services contractor, financial source, location, physical plant, or business name. Each requires an application for an amended license, with the fee, before it is implemented. Failing to seek approval “may result in sanctions upon the license holder” — civil penalties, suspension, revocation.

Budget for it: the CRC schedule puts a majority ownership transfer at $20,000 and a location change at $10,000. And these are voted at public Commission meetings — six cleared September 9 alone — so your closing date sits on a calendar you do not control.

4. What is the buyer actually giving up?

In an ordinary deal, plenty. An asset purchase steps the buyer's basis up to fair market value and lets them amortize intangibles over fifteen years under Section 197. Surrendering that deduction normally costs the seller price.

Cannabis is different, and this is the part worth keeping. One cannabis M&A tax analysis puts it in round numbers: a buyer whose structure generates a $10 million step-up in Section 197 intangibles receives $1.5 million of annual amortization over fifteen years — and none of it is deductible if the buyer's business is subject to 280E. Depreciation on production equipment can often be capitalized into inventory and recovered through COGS, so a cultivator's equipment step-up keeps some value. The goodwill step-up largely does not. Even a Section 338(h)(10) election — a stock purchase treated as an asset purchase for tax — delivers a benefit “substantially reduced for plant-touching operations.”

And 280E is still here for adult-use. The April 28, 2026 order reached FDA-approved products and marijuana held under a state medical license; a federal court upheld that medical rescheduling on September 9, 2026. Adult-use went to a DEA hearing that ran June 29 through July 15, 2026, and no recommended decision has issued. Do not price a deal on relief that has not arrived.

So the structure fight that eats two weeks in a non-cannabis deal is smaller here. The buyer is giving up less than they think. Say so.

5. What rides along with the company?

This is the real price of the structure, and it is the buyer's leverage, not yours. Buy an entity and you buy it whole: its tax years, its employment claims, its payables, and above all its compliance file.

The CRC's 2026 record is why buyers read that file line by line: Mollitiam's licenses revoked July 16, 2026 over nineteen cited violations, Verano fined $20,500, Garden State Exotix fined $10,000 on September 9. Unresolved violations commonly cut valuations 20 to 30 percent, and in an equity deal there is nothing to leave behind: everything you did not clean up gets priced, indemnified, or escrowed.

And an equity sale does not require a lease assignment, which sounds like good news until someone reads the change-of-control clause that calls it one anyway. That has ended more New Jersey deals than the CRC has.

6. Which filings change with the structure?

New Jersey's Bulk Sale Act puts the notification obligation on the purchaser: Form C-9600, in the Division of Taxation's hands at least ten business days before closing, with an escrow the Division sets that can exceed the price. A purchaser who does not notify takes on the seller's State tax obligations. The Division's own guidance lists sales of corporate stock or membership interests by individuals, estates or trusts among the exemptions.

Read that carefully rather than optimistically. Whether a deal lands inside the exemption turns on who the selling owners are, and I am a broker, not your accountant. Put it to a cannabis CPA and a New Jersey cannabis attorney before anyone drafts. Twenty-minute question, six-figure answer.